Meanwhile, The reduction of IL-6 demonstrates M-SYFSF’s anti-inflammatory effects, as IL-6 contributes to DKD through mesangial proliferation and ECM accumulation, potentially linking inflammation to fibrosis progression. Here, IL6 is linked to diabetic kidney disease.